The SBIR timeline for medtech founders
SBIR and STTR grants are the largest pool of non-dilutive capital available to medtech startups: money that funds your R&D without taking equity, and that signals scientific credibility to every investor who looks at you afterward. The catch: the timeline is long and unforgiving, and most founders start too late. Here's how the clock actually runs.
The two programs that matter most for medtech
NIH SBIR/STTR is the workhorse for health innovation: roughly $314K for Phase I (feasibility, 6-12 months) and $2M+ for Phase II (development, 2 years), with amounts varying by institute and topic. Applications go to standard receipt dates (September 5, January 5, and April 5) and are reviewed by study sections of scientists, so your application is judged as science first, business second.
NSF America's Seed Fund funds deep-tech innovation including devices and digital health: up to $305K Phase I and $1.25M Phase II. NSF requires an approved Project Pitch, a short, fast pre-screen, before you're invited to submit a full proposal. Current full-proposal deadlines are on our Deadline Tracker. NSF cares about commercial potential and technical risk; NIH cares about health impact and rigor. Many medtech companies qualify for both. Apply to the one whose reviewers will love you, or both.
The hidden timeline: registrations
Before you can submit anything federal, you need a stack of registrations, each with its own processing time: SAM.gov (can take weeks and is the notorious bottleneck), then for NIH an eRA Commons account, and SBA company registry. If you're eyeing a January 5 NIH deadline, your registrations should be moving by October.
What the full clock looks like (NIH example)
- Month 0: Start registrations; draft specific aims; talk to a program officer (they will tell you if your idea fits, so use this).
- Months 1-2: Write the application; line up letters of support; budget and subcontracts.
- Month 3: Submit at the standard due date.
- Months 6-8: Study section review and scoring.
- Months 9-12: Council review, award negotiation, and, if funded, money arrives.
That's the honest math: 9 to 12+ months from submission to funding. If your application isn't funded on the first try (most aren't; institute paylines are competitive), you revise and resubmit at a later cycle, adding another 4-8 months. Plan your runway assuming SBIR money arrives later than you hope, and never build a hiring plan on a pending application.
How to raise your odds
- Call the program officer before you write. Fit questions are free to answer and misfit applications are dead on arrival.
- Mine NIH RePORTER to see what's been funded in your space, which institutes fund it, and how winners framed their aims.
- Write for a tired reviewer. Your specific aims page decides your score; make the problem, innovation, and feasibility obvious in one page.
- Preliminary data wins. Even modest bench data separates fundable from "premature."
- Stack the calendar. NIH, NSF, and ARPA-H cycles interleave, so a company in continuous application mode always has a shot pending. The Deadline Tracker shows what's next.
After Phase I
Phase II is where the real money is, and Phase I performance plus a credible commercialization plan drives it. Massachusetts founders get an extra kicker: MassVentures START awards up to $500K in non-dilutive follow-on funding specifically for companies commercializing SBIR-funded work. Fast-track mechanisms (combined Phase I/II) exist at both NIH and NSF if your feasibility case is already strong.